Positron Emission Tomography (PET) studies rely on a specialized tracer to visualize metabolic activity within the body. This tracer, FDG, is a modified sugar molecule that is taken up in areas of high metabolic function. By administering FDG into the bloodstream and tracking its distribution through PET devices, clinicians can detect a wide range